PMGC (NASDAQ:ELAB) Rating Increased to Sell at Wall Street Zen

PMGC (NASDAQ:ELAB) was upgraded by equities researchers at Wall Street Zen to a “sell” rating in a research report issued on Saturday.

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of PMGC in a research report on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has an average rating of “Sell”.

PMGC Stock Performance

ELAB stock opened at $6.04 on Friday. The firm has a market cap of $4.11 million, a PE ratio of -0.01 and a beta of 0.32. The firm’s fifty day moving average is $5.84 and its 200 day moving average is $7.40. PMGC has a one year low of $4.28 and a one year high of $901.60.

About PMGC

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021.